RxDataScience Blog

• Kate Spade – depression and anxiety
• Robin Williams – severe depression
• Pete Davidson – Borderline Personality Disorder
• Demi Lovato – Bipolar disorder

Two gone, two battling a lifelong battle, like many Americans. With the stigma and bias surrounding the topic, the mental health community struggles to move forward. The research and treatment is at least a decade behind common chronic conditions, mainly because no one wants to talk about mental health due to the complexity and lack of understanding. 

IMS Health’s Longitudinal Access and Adjudication Data (LAAD) has revolutionized how companies view data, and structures the information in an easier way for all parties involved. In short, “LAAD is an anonymized patient sample dataset that captures longitudinal pharmacy (both retail and specialty) and medical claims. It was used to quantify payer channel distribution, co-pay card penetration, and low-income subsidy prevalence for these products.”

One life gone. Now, another. By the end of today, the Centers for Disease Control and Prevention predict that, on average, 115 Americans will die from an opioid overdose. The cycle will repeat tomorrow and the next day as well as the next.  

What was once a chilling feeling has turned numb, leaving the public unphased by the steadily increasing body count scattered across the headlines.

As each industry becomes more technologically savvy, the pharmaceutical industry has the chance to emerge into the 21^st century and reform how they treat patients while tackling different medical epidemics that affect the world today.